ArticlePloS one2023
Trends and influence factors in the prevalence, awareness, treatment, and control of hypertension among US adults from 1999 to 2018.
Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 28 citations in OpenAlex.
- Hypertension screening in adults attending family health centers: prevalence and awareness in those with and without a prior hypertension diagnosis.BMC public health · 2026Article
- Trends in unawareness of cardiovascular disease risk factors among racial & ethnic groups in the United States.American journal of preventive cardiology · 2026Article
- Hypertension Prevalence, Awareness, Treatment, and Control Among Community-Dwelling Adults in Low-Resource Neighborhoods of Chicago, Illinois.American journal of health promotion : AJHP · 2026Article
- Hypertension in Women Across the Life Cycle: Unique Aspects and Challenges.Current hypertension reports · 2026Review
- Race and Patient-Physician Communication on Blood Pressure Management: Helping Improve Care.Current cardiology reports · 2026Review
- Helicobacter pylori seroprevalence and its association with prevalent and incident blood pressure and haemoglobin A1c in the US-based National Longitudinal Study of Adolescent to Adult Health.BMJ public health · 2026Article
- Effects of altitude and sociodemographic factors on cardiometabolic disorders in the southwestern plateau areas of China.Frontiers in cardiovascular medicine · 2026Article
- Prevalence and risk factors of hypertension in Saudi Arabia based on a nationally representative survey.Frontiers in cardiovascular medicine · 2026Article
- Sex differences in the prescription of antihypertensive medications in primary care patients: an observational study.BJGP open · 2025Article
- Untreated Hypertension and Diabetes in the Chest Pain Observation Unit.The western journal of emergency medicine · 2025Observational
- Assessing Daily Antihypertensive Medication Compliance Among Black Adults Using Smartphone-Based Ecological Momentary Assessment: A Feasibility Study.Computers, informatics, nursing : CIN · 2025Article
- Burden of High Systolic Blood Pressure in the Eastern Mediterranean Region, 1990 to 2021: Results From the Global Burden of Disease Study 2021.Journal of the American Heart Association · 2025Article
- Hypertension awareness, treatment, control, and prognosis: insights from the sub-cohort of China PEACE million persons project.Hypertension research : official journal of the Japanese Society of Hypertension · 2025Article
- Article
- Nonlinear association of a composite metabolic index (ZJU index) with hypertension: a cross-sectional study of NHANES 2003-2018.Frontiers in cardiovascular medicine · 2025Article
- Body Mass Index and the Risk of Hypertension-Diabetes Comorbidity in Elderly Population: A Prospective Cohort in China.Global heart · 2025Observational
- Using the medication adherence reasons scale (MAR-scale) to identify the reasons for non-adherence in Chinese hypertensive patients.PloS one · 2025Article
- Trends in prevalence of hypertension and high-normal blood pressure among US adults, 1999-2018.Scientific reports · 2024Article
- Review
- National and Regional Trends in the Prevalence of Hypertension in South Korea Amid the Pandemic, 2009-2022: Nationwide Study of Over 3 Million Individuals.JMIR public health and surveillance · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveWe aimed to describe the trends and influence factors in the prevalence, awareness, treatment, and control of hypertension among US Adults from 1999 to 2018.
methodsWe utilized data from the National Health and Nutrition Examination Survey (NHANES) spanning ten survey cycles (n = 53,496). Prevalence, awareness, treatment, and control of hypertension were calculated using survey weights. Joinpoint regression and survey-weighted generalized linear models were used to analyze trends and influence factors, respectively.
resultsThe estimated prevalence of hypertension increased significantly from 33.53% to 40.58% (AAPC = 0.896, P = 0.002) during 1999-2018 with dropping rate of newly diagnosed hypertension from 8.62% to 4.82% before 2014 (APC = -4.075, P = 0.001), and then rose to 7.51% in 2018 (APC = 12.302, P = 0.126). Despite modest improvements or stability in the awareness, treatment, and control since 1999, the latter two remained inadequate in 2018 at 59.52% and 51.71%. There was an uptrend in the use of angiotensin-converting enzyme inhibitors (from 24.02% to 45.71%) and angiotensin receptor blockers (from 20.22% to 38.38%), and downtrend in β-blocker (from 12.71% to 4.21%). Men were at higher risk of incidence, un-awareness, un-treatment, and un-control for hypertension. Lower income and education were associated with susceptibility to hypertension, while being married was favorable for treatment and control. Optimal health reduced the incidence of hypertension, and increased the awareness and treatment.
conclusionAlthough the rate of newly diagnosed hypertension has declined slightly since 2010 in the US, the prevalence of hypertension is increasing, and treatment and control rates remain inadequate. To manage hypertension effectively, we need to focus on screening and prevention for high-risk populations, while advocating for optimal health to improve the burden of hypertension.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.